NCT00398177Recruiting
Clinical and Pathologic Studies in Non-Hodgkin's Lymphoma and Hodgkin's Disease
Source: ClinicalTrials.gov · Last updated 24 Dec 2025
Brief summary (registry, in English)
The purpose of this study is to characterize the molecular and cell biology of the tumor cells in lymphoma.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 9999 (estimated)
- First submitted
- 9 Nov 2006
- Start date
- Jan 1999
- Primary completion date
- Jan 2099
- Lead sponsor
- Stanford University
- Diseases
- Hodgkin lymphoma
- NCT number
- NCT00398177
What you commit to
- Study type: Observational
- Planned participants: 9999
- From Jan 1999 to the primary completion date, Jan 2099
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study design.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Patients without NHL or Hodgkin's disease
Who the study is looking for
- Diagnosis of Hodgkin's disease or non-Hodgkin's lymphoma, any cellular classification, any stage, any grade.
- Adult or pediatric patients receiving lymph node excision for purposes other than cancer therapy (i.e. tonsillectomy, sleep apnea).
- A routine procedure for tissue collection is planned.
- Ability to understand and the willingness to sign a written informed consent.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Stanford University School of Medicine Coordinator of this site? Confirm its status | Stanford | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.